Kory James Wentworth, CFO: Entrada Therapeutics TRDA Sell · Filed 23/07/12

Trade details

Type: Insider sale
Amount: $109,965.68
Shares · price: 6,116 sh · $17.98 a share
Held after: 36,747 sh
Stock: Entrada Therapeutics TRDA
Person: Kory James WentworthCFO
Trade date: 23/07/10
Filed: 23/07/12
Days to filing: 2 days

Sold 14.3% of holdings

Share of holding sold: 14.3%

Entrada Therapeutics trades, last 26 weeks

What else happened in Entrada Therapeutics around then

Filed or reported within 30 days of the trade day · 23/06/10~23/08/09

Kory James Wentworth's recent trades

Kory James WentworthCFO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$32.4K
2,500 sh
$32.4K
Filed 04/02
Traded 04/01
Kory James WentworthCFO
Planned sale10b5-1 planEntrada Therapeutics
Planned sale10b5-1 plan
Entrada Therapeutics
TRDA
$31.6K
2,500 sh
$31.6K
Filed 04/01
Traded 04/01
Kory James WentworthCFO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$148.3K
11,388 sh
$148.3K
Filed 03/11
Traded 03/10
Kory James WentworthCFO
Sell10b5-1 planEntrada Therapeutics
Sell10b5-1 plan
Entrada Therapeutics
TRDA
$66.2K
5,089 sh
$66.2K
Filed 03/11
Traded 03/09
Kory James WentworthCFO
Planned sale10b5-1 planEntrada Therapeutics
Planned sale10b5-1 plan
Entrada Therapeutics
TRDA
$207.3K
16,477 sh
$207.3K
Filed 03/09
Traded 03/09

Kory James Wentworth, CFO — sold $110K of Entrada Therapeutics TRDA · 14.3% of holdings · 10b5-1 plan | Whalegun